Hospira (4.2% Sodium bicarbonate injection, 8.4% Sodium bicarbonate injection, Atropine sulfate injection/Hospira, Inc.) Recall reason: Presence of Glass Particulate Matter (FDA - Food and Drug Administration)

Posted 2023-12-26, Public Technologies Headlines

) COMPANY ANNOUNCEMENT Hospira, Inc. Issues A Voluntary Nationwide Recall For 4.2% Sodium Bicarbonate Injection, 8.4% Sodium Bicarbonate Injection, and Atropine Sulfate Injection Due to the Potential Presence of Glass Particulate Matter When a company announces a recall, market withdrawal, or safety... read full story

Ask about this article

Answer for your question of the article will be displayed here ...